Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
August 14, 2023
Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy
Kadriye Bir Yücel, Atiye Cenay Karabörk Kilic, Osman Sütcüoglu, et al.
Medical Oncology (Northwood, London, England)
|
October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
Emel Yaman, Aytug Uner, Ozlem Er, et al.
Onkologie
|
June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment
Emel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Medical Oncology (Northwood, London, England)
|
December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma
Banu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
Journal of the National Medical Association
|
September 1, 2009
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer
Ugur Coskun, Necati Alkis, Gokhan Celenkoglu, et al.
Medical Oncology (Northwood, London, England)
|
February 27, 2009
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer
Ali Osman Kaya, Suleyman Buyukberber, Mustafa Benekli, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
March 5, 2009
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin
Ali Osman Kaya, Ugur Coskun, Mustafa Unlu, et al.
Journal of Cancer Research and Clinical Oncology
|
August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Oncology
|
October 19, 2012
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer
Nedim Turan, Mustafa Benekli, Dogan Koca, et al.
Thoracic Cancer
|
January 15, 2016
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer
Nedim Turan, Mustafa Benekli, Faysal Dane, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Chemotherapy (Florence, Italy)
|
August 14, 2023
Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy
Kadriye Bir Yücel, Atiye Cenay Karabörk Kilic, Osman Sütcüoglu, et al.
Medical Oncology (Northwood, London, England)
|
October 6, 2007
Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
Emel Yaman, Aytug Uner, Ozlem Er, et al.
Onkologie
|
June 13, 2008
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment
Emel Yaman, Suleyman Buyukberber, Aytug Uner, et al.
Medical Oncology (Northwood, London, England)
|
December 18, 2007
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma
Banu Ozturk, Suleyman Buyukberber, Muge Akmansu, et al.
Journal of the National Medical Association
|
September 1, 2009
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer
Ugur Coskun, Necati Alkis, Gokhan Celenkoglu, et al.
Medical Oncology (Northwood, London, England)
|
February 27, 2009
Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer
Ali Osman Kaya, Suleyman Buyukberber, Mustafa Benekli, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
March 5, 2009
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin
Ali Osman Kaya, Ugur Coskun, Mustafa Unlu, et al.
Journal of Cancer Research and Clinical Oncology
|
August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Oncology
|
October 19, 2012
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer
Nedim Turan, Mustafa Benekli, Dogan Koca, et al.
Thoracic Cancer
|
January 15, 2016
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer
Nedim Turan, Mustafa Benekli, Faysal Dane, et al.
Page
of 5